Hematologic Malignancies Updates: Leukemias, Lymphomas, & Myeloma 2021 - A Virtual Series

The faculty will present the latest research on treatment modalities for hematologic malignancies—leukemias, lymphomas, and myeloma—along with case studies for these diagnoses.

The program takes place virtually on:

May 15th with Case Presentations from Stanford University
September 11th with Case Presentations from UC Davis
November 13th with Case Presentations from UC San Francisco (Potentially in Person)

Presentations begin at 9:00 am. The program will conclude by 12:30pm

ANCO acknowledges the support of AbbVie, AstraZeneca, Bristol-Myers Squibb, GSK, Morphosys, Pharmacyclics, and Takeda in making this program possible.

Register online: tiny.cc/ANCOHMU2021